Abstract |
We assessed the clinical and biochemical effects in asthmatic children of fish oil supplementation and a diet that increases omega-3 and reduces omega-6 fatty acids. Thirty nine asthmatic children aged 8-12 yrs participated in a double-blind, randomized, controlled trial for 6 months during which they received fish oil capsules plus canola oil and margarine (omega-3 group) or safflower oil capsules plus sunflower oil and margarine (omega-6 group). Plasma fatty acids, stimulated tumour necrosis factor alpha ( TNFalpha) production, circulating eosinophil numbers and lung function were measured at baseline and after 3 and 6 months of dietary modification. Day and night symptoms, peak flow rates and medication use were recorded for 1 week prior to laboratory visits. Plasma phospholipid omega-3 fatty acids were significantly greater in the omega-3 group at 3 and 6 months compared to the omega-6 group (p<0.001). In the omega-3 group TNFalpha production fell significantly compared with baseline (p=0.026), but the magnitude of change between groups did not reach significance (p=0.075). There were no significant changes in clinical outcome measures. Dietary enrichment of omega-3 fatty acids over 6 months increased plasma levels of these fatty acids, reduced stimulated tumour necrosis factor alpha production, but had no effect on the clinical severity of asthma in these children.
|
Authors | L Hodge, C M Salome, J M Hughes, D Liu-Brennan, J Rimmer, M Allman, D Pang, C Armour, A J Woolcock |
Journal | The European respiratory journal
(Eur Respir J)
Vol. 11
Issue 2
Pg. 361-5
(Feb 1998)
ISSN: 0903-1936 [Print] England |
PMID | 9551739
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Dietary Fats
- Fatty Acids, Omega-3
- Fatty Acids, Omega-6
- Fatty Acids, Unsaturated
- Tumor Necrosis Factor-alpha
|
Topics |
- Asthma
(blood, physiopathology)
- Blood Cell Count
- Child
- Dietary Fats
(therapeutic use)
- Eosinophils
(pathology)
- Fatty Acids, Omega-3
(therapeutic use)
- Fatty Acids, Omega-6
- Fatty Acids, Unsaturated
(therapeutic use)
- Forced Expiratory Volume
(physiology)
- Humans
- Lung
(physiopathology)
- Monocytes
(metabolism)
- Tumor Necrosis Factor-alpha
(biosynthesis)
|